GLP-1 Medicines in India: Brands, Generics and Makers
Semaglutide and tirzepatide in India: the brands and generics, who makes them, dated prices from named sources, and what is not sold here.
Summaries built from public sources: US prescribing labels, the trials, NHS pages, Indian news and CDSCO records. Every claim carries its source. Nothing here replaces your doctor's advice.
Semaglutide and tirzepatide in India: the brands and generics, who makes them, dated prices from named sources, and what is not sold here.
Patches and supplements sold as GLP-1 are not GLP-1 medicines. What a regulator found inside, what berberine did in trials, and how India regulates each.
GLP-1 tablets found in India are oral semaglutide for type 2 diabetes. The Wegovy pill and orforglipron: US approvals, no Indian launch found (Oct 2026).
Mounjaro (tirzepatide) vs semaglutide: the head-to-head trial and who ran it, what the averages mean, side effects against placebo, and what India sells.
Nausea, acidity, constipation and hair loss on semaglutide and tirzepatide: how often each happens, what generally helps, and when to see a doctor.
Under the US label, the semaglutide injection rises from 0.25 mg to 2.4 mg in 4-week steps. See each step, the reason, and the US missed-dose rule.
Nausea, constipation, acidity and hair loss on semaglutide: how often they happen, why they peak as the dose rises, and when to call your doctor.
Tirzepatide, semaglutide and GLP-1 tablets: each trial's results and side effects, what is sold in India in 2026, and why a doctor decides.
How safe GLP-1 treatment is depends on the person: who must not take it, who needs extra checks first, and the prescription rules in India.